Ginkgo Biloba
Ginkgo biloba is one of the most extensively studied herbs for cognitive function, with a unique combination of mechanisms targeting cerebrovascular circulation, platelet-activating factor (PAF) inhibition, and antioxidant activity. EGb 761 (standardized extract) is the most studied formulation. Meta-analyses confirm modest but significant improvements in cognitive symptoms of dementia and age-related cognitive decline. Civilian and military studies show acute cognitive benefits in healthy adults. Bilobalide has neuroprotective properties distinct from its vascular effects. One of the most used supplements globally, with a robust safety profile.
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
No formal phase listed
Research Sync
Not synced yet
Dosing
Pharmacology
Evidence Score
Plain-English Snapshot
Ginkgo Biloba is currently categorized as a nootropic compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
PAF (platelet-activating factor) antagonism; inhibits phosphodiesterase → increased cGMP; free radical scavenging (flavonoids); inhibits EAA receptor-mediated excitotoxicity (bilobalide)
Practical Context
Strongest current signals
No indexed study summaries yet.